Osteogenic Effect of Fisetin Doping in Bioactive Glass/Poly(caprolactone) Hybrid Scaffolds
Open Access
- 21 June 2022
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 7 (26) , 22279-22290
Abstract
Treating large bone defects or fragile patients may require enhancing the bone regeneration rate to overcome a weak contribution from the body. This work investigates the osteogenic potential of nutrient fisetin, a flavonoid found in fruits and vegetables, as a doping agent inside the structure of a SiO2-CaO bioactive glass-poly(caprolactone) (BG-PCL) hybrid scaffold. Embedded in the full mass of the BG- PCL hybrid during one-pot synthesis, we demonstrate fisetin to be delivered sustainably; the release follows a first-order kinetics with active fisetin concentration being delivered for more than 1 month (36 days). The biological effect of BG-PCL-fisetin-doped scaffolds (BG-PCL-Fis) has been highlighted by in vitro and in vivo studies. A positive impact is demonstrated on the adhesion and the differentiation of rat primary osteoblasts, without an adverse cytotoxic effect. Implantation in critical-size mouse calvaria defects shows bone remodeling characteristics and remarkable enhancement of bone regeneration for fisetin-doped scaffolds, with the regenerated bone volume being twofold that of nondoped scaffolds and fourfold that of a commercial trabecular bovine bone substitute. Such highly bioactive materials could stand as competitive alternative strategies involving biomaterials loaded with growth factors, the use of the latter being the subject of growing concerns.Keywords
Funding Information
- European Regional Development Fund
- R?gion Auvergne-Rh?ne-Alpes
This publication has 66 references indexed in Scilit:
- Clinical sequelae after rhBMP-2 use in a minimally invasive transforaminal lumbar interbody fusionThe Spine Journal, 2013
- The Polyphenol Fisetin Protects Bone by Repressing NF-κB and MKP-1-Dependent Signaling Pathways in OsteoclastsPLOS ONE, 2013
- Transforaminal Lumbar Interbody Fusion With rhBMP-2 in Spinal Deformity, Spondylolisthesis, and Degenerative Disease–Part 1Spine, 2013
- In vivo osteoinductivity of gelatin β-tri-calcium phosphate sponge and bone morphogenetic protein-2 on an equine third metacarpal bone defectResearch in Veterinary Science, 2012
- Mesoporous bioactive glass scaffolds for efficient delivery of vascular endothelial growth factorJournal of Biomaterials Applications, 2012
- A randomized‐controlled clinical trial evaluating clinical and radiological outcomes after 3 and 5 years of dental implants placed in bone regenerated by means of GBR techniques with or without the addition of BMP‐2Clinical Oral Implants Research, 2009
- MicroCT Evaluation of Three-Dimensional Mineralization in Response to BMP-2 Doses In Vitro and in Critical Sized Rat Calvarial DefectsTissue Engineering, 2007
- Paraffin spheres as porogen to fabricate poly(L‐lactic acid) scaffolds with improved cytocompatibility for cartilage tissue engineeringJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2003
- Influence of hydrodynamic shear stress on microcarrier-attached cell growth: Cell line dependency and surfactant protectionBioprocess and Biosystems Engineering, 1999
- A Simple Model Based on First Order Kinetics to Explain Release of Highly Water Soluble Drugs from Porous Dicalcium Phosphate Dihydrate MatricesDrug Development and Industrial Pharmacy, 1995